14 completed, 3 terminated, 2 recruiting, 2 unknown. 22 Phase 2, 6 Phase 1, 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 22 | Completed 14, Terminated 3, Recruiting 2, Unknown 2, Withdrawn 1 |
| Phase 1 | 6 | Completed 4, Terminated 2 |
| Phase 3 | 5 | Completed 1, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1 |
Follow Wound Healing: new trials by email Literature Review of Wound Healing trials Research Report on Wound Healing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lactoferrin Nanohydrogel for Soft And Hard Tissue Healing and Implant Stability in Immediate Implant Placement 4% bovine lactoferrin nanohydrogel - Dental Implant, Wound Healing | Phase 2 / Phase 3 | Recruiting | Future University in Egypt | 20 | 2026-06-05 | 2026-10-27 |
| Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction RhPDGF-BB, Saline - Wound Healing, Surgical Wound | Phase 2 | Completed | Vanderbilt University Medical Center | 36 | 2025-04-01 | 2026-08-12 |
| Silver Nitrate vs. Triamcinolone for Treatment of Hypergranulation Tissue Silver Nitrate, triamcinolone, Silver nitrate + triamcinolone - Wound Healing, Granulation Tissue | Phase 2 / Phase 3 | Withdrawn | Francesco Egro | 2025-03-01 | 2026-07-22 | |
| Dose Regimen Study of SLI-F06 in Healthy Volunteers SLI-F06 - Scar, Wound Healing | Phase 2 | Recruiting | Scarless Laboratories, Inc. | 30 | 2022-07-25 | 2023-07-27 |
| Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants TolaSure Topical Gel, Topical Vehicle Gel - Wound Healing | Phase 2 | Completed | BioMendics, LLC | 72 | 2019-08-26 | 2021-06-24 |
| Controlled Comparison of a Traditional Dressing Versus a Biologic Dressing Composed of Fetal Fibroblasts and Keratinocytes in Association With a Collagen Matrix on Skin Donor Sites biological dressing, Paraffin gauze dressing - Split Thickness Skin Graft, Wound Healing | Phase 1 / Phase 2 | Terminated | Nantes University Hospital | 28 | 2018-05-16 | 2024-08-12 |
| Prevena™ Incision Management System vs Conventional Management for Wound Healing incisional negative pressure wound therapy, conventional dressing - Wound Healing, Prevena | Phase 2 | Unknown | Ospedale Misericordia e Dolce | 120 | 2014-11-01 | 2016-09-08 |
| VADOplex Critical Limb Ischemia Study VADOplex system - Peripheral Artery Disease, Quality of Life | Phase 2 / Phase 3 | Unknown | Asklepios Kliniken Hamburg GmbH | 38 | 2013-10-01 | 2014-01-13 |
| Tyrosur® Gel-Investigation on Wound Healing Efficacy Drug containing the active ingredient, Placebo - Wounds, Wound Healing | Phase 2 | Completed | Engelhard Arzneimittel GmbH & Co.KG | 33 | 2010-09-01 | 2010-10-26 |
| Rationales for Wound Care Management in Old World Cutaneous Leishmaniasis Patients Electro-thermo-coagulation, Sodium Stibogluconate, DAC N-055 - Wound Healing | Phase 2 | Completed | Waisenmedizin e. V. Promoting Access to Essential Medicine | 63 | 2010-01-01 | 2011-03-28 |
| Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds Procellera (Bioelectric Wound Dressing), Opsite (Transparent Adhesive Dressing) - Burns, Wound Healing | Phase 1 / Phase 2 | Completed | Vomaris Innovations | 17 | 2009-09-01 | 2010-12-10 |
| Efficacy Study of a Bioelectric Dressing Used With Negative Pressure Wound Therapy to Treat Diabetic and Pressure Ulcers Procellera™ Wound Dressing with V.A.C.® Therapy, V.A.C.® Therapy - Wound Healing | Phase 2 | Completed | Vomaris Innovations | 30 | 2009-08-01 | 2012-02-22 |
| Clinical Trial to Investigate Treatment With Photodynamic Therapy to Reduce Levels of Bacteria in Leg Ulcers Topical PPA904 gel and light, Topical placebo gel plus light - Chronic Leg Ulcers, Wound Healing | Phase 2 | Completed | Photopharmica | 57 | 2009-01-01 | 2013-01-24 |
| Efficacy Study of a Bioelectric Dressing to Treat Wounds Caused by Curettage and Electrodesiccation Procellera™ Antimicrobial Wound Dressing, ACTICOAT™ Antimicrobial Barrier Dressing, Mepilex® Ag Silver Foam Dressing - Wound Healing, Wound Infection | Phase 2 | Completed | Vomaris Innovations | 15 | 2008-07-01 | 2009-10-29 |
| Effects of Pulsatile Intravenous (IV) Insulin on Wound Healing in Diabetics Pulsatile Intravenous Insulin Therapy - Wound Healing, Diabetes | Phase 2 / Phase 3 | Terminated | Florida Atlantic University | 152 | 2006-01-01 | 2016-08-10 |
| Investigation Into the Scar Reduction Potential of Prevascar (Interleukin-10) Prevascar, Placebo - Cicatrix, Wound Healing | Phase 2 | Completed | Renovo | 175 | 2005-04-01 | 2009-09-25 |
| Rationale for New Topical Anthroponotic Cutaneous Leishmaniasis (ACL) Treatment in Kabul Electro-thermo-coagulation, DAC N-055, saline - Wound Healing | Phase 2 / Phase 3 | Completed | Waisenmedizin e. V. Promoting Access to Essential Medicine | 134 | 2004-08-01 | 2025-08-08 |
| Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites Avotermin, Placebo - Cicatrix, Wound Healing | Phase 2 | Completed | Renovo | 102 | 2003-10-01 | 2009-09-25 |
| Topical Hydromorphone for Wound Healing hydromorphone - Wound Healing | Phase 1 / Phase 2 | Terminated | Hordinsky, Maria K., MD | 50 | 2003-10-01 | 2010-03-01 |
| Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects Avotermin, Placebo - Cicatrix, Wound Healing | Phase 1 / Phase 2 | Completed | Renovo | 35 | 2003-04-01 | 2009-09-25 |
Showing 20 of 22. Sign in to see all of them.
Cicatrix (6) · Wounds and Injuries (4) · Burns (1) · Chronic Limb-Threatening Ischemia (1) · Diabetes Mellitus (1) · Diabetic Foot (1) · Leg Ulcer (1) · Peripheral Arterial Disease (1) · Pressure Ulcer (1) · Surgical Wound (1) · Wound Infection (1)
Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Fibrosis (6) · Cardiovascular Diseases (2) · Endocrine System Diseases (2) · Skin Diseases (2) · Skin Ulcer (2) · Skin and Connective Tissue Diseases (2) · Vascular Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Atherosclerosis (1) · Chronic Disease (1) · Diabetes Complications (1) · Diabetes Mellitus (1)
TGFB3 protein, human (4) · Transforming Growth Factor beta3 (3) · Sodium Chloride (2) · Acticoat (1) · Antimony Sodium Gluconate (1) · Becaplermin (1) · Biological Dressings (1) · Hydromorphone (1) · Insulin (1) · Insulin Aspart (1) · Insulin, Regular, Human (1) · Interleukin-10 (1) · Light (1) · Ltbp3 protein, zebrafish (1) · Negative-Pressure Wound Therapy (1)
Renovo (5) · Vomaris Innovations (3) · Waisenmedizin e. V. Promoting Access to Essential Medicine (2) · Asklepios Kliniken Hamburg GmbH (1) · BioMendics, LLC (1) · Engelhard Arzneimittel GmbH & Co.KG (1) · Florida Atlantic University (1) · Francesco Egro (1) · Future University in Egypt (1) · Hordinsky, Maria K., MD (1) · Nantes University Hospital (1) · Ospedale Misericordia e Dolce (1) · Photopharmica (1) · Scarless Laboratories, Inc. (1) · Vanderbilt University Medical Center (1)
United States (9) · United Kingdom (6) · Afghanistan (2) · Egypt (1) · France (1) · Germany (1) · Italy (1)
Jonathan Duncan (4) · James Bush (2) · Jeremy Bond (2) · Michael J Davies (2) · Andrew L Blount, MD (1) · Betty Tuller, PhD (1) · Elisabeth J Leeflang, MD (1) · Francesco Feroci, MD (1) · Francesco M Egro, MD, MSc, MRCS (1) · Holger Lawall, MD (1) · Keith Harding, MBChB FRCS (1) · Lobna A Aly, Professor (1) · Maria Hordinsky, MD (1) · Richard Wilcox, MD (1)
PMID 24551257, PMID 25420793, PMID 29898959, PMID 31661012, PMID 40952157, PMID 42145621